Cervical Radiculopathy is a condition characterised by the compression of the cervical spinal nerve roots, which manifests with painful symptoms and functional limitations.
A recent research, “Clinical Efficiency Of High-Intensity Laser Therapy In Patients With Cervical Radiculopathy: A 12-Week Follow-Up, Randomised, Placebo-Controlled Trial.” investigated the combined application of Hilterapia® (with the Hiro 3.0 device) and physical exercise in the treatment of Cervical Radiculopathy (CR).
The study involved a sample of 90 patients diagnosed with cervical disc herniation. Participants were randomly assigned to one of three treatment groups: Hilterapia® combined with exercise (HILT + EX), placebo combined with exercise (Placebo + EX), and exercise alone (EX only).
Several parameters were assessed to measure the effectiveness of the treatment, including:
The treatment protocol with Hilterapia® involved a total of 20 sessions, with a frequency of 5 sessions a week for 4 weeks.
Each session included three phases (scan, sensitive trigger points, slow scan) and had a total duration of 20 minutes.
During each session, a total energy of 2632 J was applied.
Individuals were evaluated by an independent investigator, who was unaware of the treatment group, at the start of the study (T0), after 4 weeks (T1 - end of treatment) and after 12 weeks (T2) from the start of the treatment cycle.
The results highlighted that, although the placebo effects influenced the results, the group that underwent the combination of Hilterapia® and physical exercise (Hilterapia® + EX) showed significant improvement in pain reduction (VAS), in the control of neuropathic pain (PD-Q), in the impact of radicular pain (CRIS) and in neck disability (NDI) in both the short and medium term.
Furthermore, the Hilterapia® + EX group demonstrated a clear superiority over the other groups in the medium term, as concerns the increase of the cervical range of motion in the directions of extension (p=0.005), right rotation (p=0.013) and right lateral tilt (p<0.001).
Interestingly, the Hilterapia® + EX group also reported significant improvement in all SF-36 sub-parameters compared to the other two groups. It should be emphasised that no adverse effects were found during treatment and follow-up, neither with Hilterapia®, nor with placebo, nor with physical exercise.
In conclusion, the association between Hilterapia® and physical exercise proved to be superior to placebo or physical exercise alone in reducing radicular pain and improving the functionality and quality of life of patients suffering from Cervical Radiculopathy. It is important to underline that these benefits have been maintained in the medium term.
The results obtained provide solid evidence of the efficacy of this non-invasive therapy in improving the well-being of patients suffering from this painful condition.
L'accesso alla visualizzazione dei prodotti e al materiale informativo è riservato agli operatori del settore in ottemperanza alla legislazione vigente. ASA richiede di qualificarsi come operatore del settore per procedere con la navigazione.
Decreto Legislativo 24 febbraio 1997, n°46 Articolo 21
1. E' vietata la pubblicità verso il pubblico dei dispositivi che, secondo disposizioni adottate con decreto del Ministro della Sanità, possono essere venduti soltanto su prescrizione medica o essere impiegati eventualmente con l'assistenza di un medico o di altro professionista sanitario.
2. La pubblicità presso il pubblico dei dispositivi diversi da quelli di cui al comma 1 è soggetta ad autorizzazione del Ministero della Sanità. Sulle domande di autorizzazione esprime parere la Commissione di esperti prevista dall'articolo 6, comma 3, del decreto legislativo
30 dicembre 1992, n. 541, che a tal fine è integrata da un rappresentante del Dipartimento del Ministero della Sanità competente in materia di dispositivi medici e da uno del Ministero dell'Industria, del commercio e dell'artigianato.
Some of the contents of this website cannot be disclosed in the USA and its territories and possesions, for regulatory reasons. If you are a US resident, please click on the button here below and access ASA's distributor website for North America.